|
|
|
LifeScienceHistory.com - Check us out on Instagram
Washington Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing WashingtonLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Faraday Pharmaceuticals
| | | Phone: | (206) 492-5310 | Year Established: | 2014 | Main Contact: | Stephen A. Hill, M.D., CEO | | Other Contacts: | Simon J. Tulloch, Dip Pharm Med, CMO Brian Blackman, CFO & CBO Mark B. Roth, Ph.D., President
| | Company Description | Faraday Pharmaceuticals is a biopharmaceutical company pursuing the development of elemental reducing agents (ERAs). This pioneering approach focuses on the ability of specific reduced forms of elements to improve outcomes for patients. | |
|
|
|
|
|